Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Prostaglandins Other Lipid Mediat. 2014 May 29;0:21–29. doi: 10.1016/j.prostaglandins.2014.05.002

Figure 1.

Figure 1

Pre- and post-treatment LC PUFA status of subjects (n=10). A) Ratio of LC PUFAs in erythrocyte membranes at baseline (t0) and after twelve weeks (t12) of treatment with LC n-3 PUFA. B) Mean relative change of LC PUFA ratios after LC n-3 PUFA treatment on individual level. All results are shown as the mean ± SE. Significant differences between the two time points were determined by dependent sample t-test.

HHS Vulnerability Disclosure